The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses.
about
Monitoring Allergen Immunotherapy Effects by MicroarrayCellular immune response parameters that influence IgE sensitizationAllergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific ImmunotherapySublingual immunotherapy: World Allergy Organization position paper 2013 update.A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE.Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy.Epitope specificity determines cross-protection of a SIT-induced IgG4 antibodyAllergen immunotherapy: a centenary celebrationProtocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE).Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice.Mechanisms of sublingual immunotherapy.Development of cockroach immunotherapy by the Inner-City Asthma Consortium.CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells.Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives.Molecular diagnosis of peanut allergy.Immunotherapy in all aspects.Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.Novel approaches and perspectives in allergen immunotherapy.Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'.Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapy.Synchronous Immune Alterations Mirror Clinical Response During Allergen Immunotherapy.Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.Amb a 1 isoforms: Unequal siblings with distinct immunological features.Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.A Recombinant Fragment of Human Surfactant Protein D Suppresses Basophil Activation and T-Helper Type 2 and B-Cell Responses in Grass Pollen-induced Allergic Inflammation.The Use of Biomarkers to Predict Aero-Allergen and Food Immunotherapy Responses.IgE+ B cells are scarce, but allergen-specific B cells with a memory phenotype circulate in patients with allergic rhinitis.Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study.Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement.Sub-lingual immunotherapy: world allergy organization position paper 2009.Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT
P2860
Q26743503-2E8F79D4-7214-41E2-88C3-619171FE3A50Q26823029-394417F5-B098-445B-A2A1-140D4C268CEBQ26852113-B5B3A878-E95F-448F-8036-3817CB32F95EQ30440195-6D2CE6D2-24F8-431E-8A3C-7A0621D09C01Q34106036-4A2F583E-FDAF-491C-97C2-EFC36414DC04Q34508199-4FD3EBC0-F8FB-45B0-A867-13DD67BC1791Q36024279-98A9A7E3-09E4-4B1A-BF7C-0AB8537AE138Q36472423-54F46B05-584B-475F-A963-1AA8BD24FCC3Q36834569-E93BA01B-85F1-4F1C-919A-519C9416C4FEQ37153212-54B9F8D2-4783-4252-9F8C-D756C26BCBBAQ37260025-C8007249-8ECE-4CE4-ACDF-840CBA85A767Q37502904-4D4FEF0B-BA7B-40AC-9B1B-9E1E61F7627AQ37619557-A6CF4430-2605-4F7D-BF27-DA6868BD40F5Q37660379-5B5C66DC-EC8C-4128-A975-BF9C4FFF9659Q37958561-08452134-828C-4333-90FE-FF3C7CA1547BQ38068226-4B39E534-3E4C-4326-A9DB-58D98C9073C7Q38352179-781CD5A7-87F3-44B4-A27D-FD9177E6FB4BQ39093744-66BD9D51-5D73-4C03-8852-6960FE4C5045Q39103046-A5413845-7019-4EB4-AAFF-E6FF41EEB35BQ39115606-A0276594-F4AE-43C6-AAF5-DE53B43E5DC8Q39735261-DA38E4F2-3355-4394-815A-78FC1F4BBFB6Q41262793-498E2CC2-3530-4DC3-B522-DB41D9E4A0CDQ45072722-DAF1AEFD-2F7E-4E1B-8B46-D9955DBBE85BQ45411915-42D89C09-617C-4213-896F-328651C79A2BQ47100827-545189EA-7694-450F-B71C-EE14D29CED90Q47437171-32ECAA2B-0E28-48D5-B2C0-48125776E36FQ47660259-64AB1126-9CA1-4B45-8D4D-8E594E8CC15AQ47796266-899D4867-1827-4F80-8686-72C1DEBFD1A8Q49891958-B7B87709-31FD-471E-BE09-F10B94F20C85Q50760318-055EBE36-93AC-4350-8D59-4EEA3364E1CFQ51663821-B9A486E8-A723-4ADE-A362-61D0FBED35AEQ55277398-6CC6D7F6-AA58-4761-B871-A46A1821B711Q55527154-10157893-1478-4161-9E98-752C57359E25Q58580218-9A1AF6E3-DB7C-4AB8-B82D-FF5AB57FFDAB
P2860
The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The IgE-facilitated allergen b ...... inhibitory antibody responses.
@ast
The IgE-facilitated allergen b ...... inhibitory antibody responses.
@en
type
label
The IgE-facilitated allergen b ...... inhibitory antibody responses.
@ast
The IgE-facilitated allergen b ...... inhibitory antibody responses.
@en
prefLabel
The IgE-facilitated allergen b ...... inhibitory antibody responses.
@ast
The IgE-facilitated allergen b ...... inhibitory antibody responses.
@en
P2093
P2860
P1476
The IgE-facilitated allergen b ...... inhibitory antibody responses.
@en
P2093
Ian Kimber
James N Francis
Louisa K Wilcock
Mark Larché
Mohamed H Shamji
Peter A Wurtzen
Petra A Wachholz
Rebecca J Dearman
Stephen R Durham
P2860
P356
10.1016/J.JIM.2006.09.004
P577
2006-10-05T00:00:00Z